Tumor derived carbohydrate binding protein
US5681923A · kind A · utility
22Cited by
1References
2Claims
0Family size
Inventor
Key dates
| Filing date | Oct 6, 1995 |
| Grant date | Oct 28, 1997 |
| Priority date | — |
| Expiry date | Oct 6, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/18
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The active, galactose binding site of proteins associated with metastatic tumor cells has been identified and sequenced (SEQ. ID. NO:1). The polypeptide comprising the active site may be used as an immunotherapeutic agent. Identification of the site makes possible an in vivo diagnostic assay for metastatic cells as well as therapeutic methodologies and materials.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.